The Cooper Companies, Inc. (COO) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for The Cooper Companies, Inc. (COO:NASDAQ), powered by AI.

Current Price
$67.35
P/E Ratio
35.2
Market Cap
13.2B
Sector
Healthcare
What is the The Cooper Companies, Inc. stock price forecast?

The Cooper Companies, Inc. is currently trading at $67.35. View real-time AI analysis on Alpha Lenz.

What is The Cooper Companies, Inc. insider trading activity?

View the latest insider trading data for The Cooper Companies, Inc. on Alpha Lenz.

What is The Cooper Companies, Inc.'s P/E ratio?

The Cooper Companies, Inc.'s P/E ratio is 35.2.

The Cooper Companies, Inc.

NASDAQ · COO
$67.35-0.41(-0.61%)Pre-marketNASDAQ regular session 09:30–16:00 ET
Ask about The Cooper Companies, Inc.'s future dividend policy...
Alpha Chat Insight

The Cooper Companies, Inc. trades at a P/E of 35.2 (premium valuation) with modest ROE of 4.6%.

Ask for details

Company Overview

The Cooper Companies Inc. is a global healthcare company that specializes in the production of medical devices, prominently focusing on contact lenses and women's health products. As a key player in the healthcare market, Cooper Companies owns two primary business units: CooperVision and CooperSurgical. CooperVision is renowned for its comprehensive range of soft contact lenses, catering to various vision correction needs such as astigmatism, presbyopia, and myopia control. Meanwhile, CooperSurgical provides innovative products and services focused on women's health, from fertility and lab solutions to surgical tools for gynecological procedures. This diversified business model allows Cooper Companies to impact multiple facets of the healthcare industry, supporting healthcare professionals and enhancing patient care. Headquartered in San Ramon, California, The Cooper Companies is significant in advancing optical technologies and essential medical devices, exemplifying growth within the global healthcare and medical device sectors.

CEOMr. Albert G. White III
SectorHealthcare
IndustryMedical Instruments & Supplies
Employees16,000

Company Statistics

FY 2025

Profile

$13.19BMarket Cap
$4.09BRevenue
0.00Shares Out
16,000Employees

Margins

65.54%Gross
25.70%EBITDA
16.69%Operating
13.84%Pre-Tax
9.16%Net

Valuation

35.19P/E
1.60P/B
3.22EV/Sales
14.82EV/EBITDA
30.42P/FCF

Growth (CAGR)

7.35%Rev 3Yr
10.98%Rev 5Yr
10.39%Op Inc 3Yr
16.98%Op Inc 5Yr
-0.95%Net Inc 3Yr
9.48%Net Inc 5Yr

Returns

3.03%ROA
4.59%ROE
5.39%ROIC

Financial Health

$110.60MCash & Cash Equivalents
$4.05BNet Debt
50.44%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

The Cooper Companies, Inc. (ticker: COO) is a company listed on NASDAQ in the Healthcare sector (Medical Instruments & Supplies). It has approximately 16,000 employees. Market cap is $13.2B.

The current price is $67.35 with a P/E ratio of 35.19x and P/B of 1.6x.

ROE is 4.59% and operating margin is 16.69%. Annual revenue is $4.1B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
The Cooper Companies, Inc. (COO) Stock Forecast 2026 $67.35 — Price, Financials & Analyst Targets | Alpha Lenz